ArticleFuture oncology (London, England)2025

Evaluating patients on CDK-4/6 inhibitor treatment for differences in treatment according to demographic variables.

Sneha Rajendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.